These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7009388)

  • 1. Nafenopin.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():125-33. PubMed ID: 7009388
    [No Abstract]   [Full Text] [Related]  

  • 2. Clofibrate.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():39-58. PubMed ID: 7009400
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatocellular carcinomas in acatalasemic mice treated with nafenopin, a hypolipidemic peroxisome proliferator.
    Reddy JK; Rao S; Moody DE
    Cancer Res; 1976 Apr; 36(4):1211-7. PubMed ID: 177202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant tumors in rats fed nafenopin, a hepatic peroxisome proliferator.
    Reddy JK; Rao MS
    J Natl Cancer Inst; 1977 Dec; 59(6):1645-50. PubMed ID: 200757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenelzine and phenelzine sulphate.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():175-84. PubMed ID: 7009391
    [No Abstract]   [Full Text] [Related]  

  • 6. Dapsone.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():59-76. PubMed ID: 7009401
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifampicin.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():243-58. PubMed ID: 7009395
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenoxybenzamine and phenoxybenzamine hydrochloride.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():185-94. PubMed ID: 7009392
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenacetin.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():135-61. PubMed ID: 7009389
    [No Abstract]   [Full Text] [Related]  

  • 10. Proflavine, proflavine dihydrochloride, proflavine hemisulphate and proflavine monohydrochloride.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():195-209. PubMed ID: 7009393
    [No Abstract]   [Full Text] [Related]  

  • 11. Methoxsalen.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():101-24. PubMed ID: 6937435
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclophosphamide.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():165-202. PubMed ID: 6944258
    [No Abstract]   [Full Text] [Related]  

  • 13. Prednisone.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():293-309. PubMed ID: 6944264
    [No Abstract]   [Full Text] [Related]  

  • 14. Increase of muscle peroxisomal enzymes and myotonia induced by nafenopin, a hypolipidemic drug.
    Behrens MI; Soza MA; Inestrosa NC
    Muscle Nerve; 1983 Feb; 6(2):154-9. PubMed ID: 6855799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydralazine and hydralazine hydrochloride.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():85-100. PubMed ID: 7009403
    [No Abstract]   [Full Text] [Related]  

  • 16. Sulfamethoxazole.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():285-95. PubMed ID: 7009398
    [No Abstract]   [Full Text] [Related]  

  • 17. Sulfafurazole (sulphisoxazole).
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():275-84. PubMed ID: 7009397
    [No Abstract]   [Full Text] [Related]  

  • 18. Spironolactone.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():259-73. PubMed ID: 7009396
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenazopyridine and phenazopyridine hydrochloride.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():163-73. PubMed ID: 7009390
    [No Abstract]   [Full Text] [Related]  

  • 20. Azathioprine.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():47-78. PubMed ID: 6944268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.